Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 10/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.54 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.46 |
| ▸ | SCD | O00767 | 1/20 | 0.46 |
| ▸ | CBFB | Q13951 | 1/20 | 0.44 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7778063 | 0.86 | CA2 (0.51) | PTGS2PTGS1 | |
| SCHEMBL28147345 | 0.82 | PTGS2 (0.74) | PTGS2PTGS1TGFBR1SCD | |
| SCHEMBL7780899 | 0.81 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL8113038 | 0.81 | SMN1; SMN2 (0.46) | TGFBR1LRRK2 | |
| SCHEMBL8229590 | 0.79 | PTGS2 (0.64) | PTGS2PTGS1TGFBR1SCDCBFB | |
| SCHEMBL7780838 | 0.79 | PTGS2 (0.54) | PTGS2PTGS1LRRK2 | |
| SCHEMBL7856946 | 0.79 | TGFBR1 (0.51) | TGFBR1 | |
| SCHEMBL7773387 | 0.78 | PTGS2 (0.49) | PTGS2PTGS1 | |
| SCHEMBL3463943 | 0.77 | KDM4E (0.48) | LRRK2 | |
| SCHEMBL7780720 | 0.77 | PTGS2 (0.68) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772597-B1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-1127878-A1 | 3,4 - substituted pyrazoles for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2001-08-29 | — | — | EP | disclosed |
| US-6028072-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | disclosed |
| US-5580985-A | ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION | G. D. SEARLE & CO. (US) | 1996-12-03 | — | — | US | disclosed |
| US-5486534-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1996-01-23 | — | — | US | disclosed |